首页> 外文期刊>Pharmaceutical Methods >Development and validation of the liquid chromatography-tandem mass spectrometry method for quantitative estimation of candesartan from human plasma
【24h】

Development and validation of the liquid chromatography-tandem mass spectrometry method for quantitative estimation of candesartan from human plasma

机译:液相色谱-串联质谱法从人血浆中定量评估坎地沙坦的开发与验证

获取原文
           

摘要

Introduction:A simple and sensitive liquid chromatography-tandem mass spectrometry method was developed and validated for estimation of candesartan in human plasma using the protein precipitation technique.Materials and Methods:The chromatographic separation was performed on reverse phase using a Betasil C8 (100 × 2.1 mm) 5-μm column, mobile phase of methanol:ammonium tri-floro acetate buffer with formic acid (60:40 v/v) and flow rate of 0.45 ml/min. The protonated analyte was quantitated in positive ionization by multiple reaction monitoring with a mass spectrometer. The mass transitions m/z 441.2 → 263.2 and 260.2 → 116.1 were used to measure candesartan by using propranolol as an internal standard.Results:The linearity of the developed method was achieved in the range of 1.2–1030 ng/ml (r2 ≥ 0.9996) for candesartan.Conclusion:The developed method is simple, rapid, accurate, cost-effective and specific; hence, it can be applied for routine analysis in pharmaceutical industries.
机译:简介:建立了一种简单灵敏的液相色谱-串联质谱法,并通过蛋白质沉淀技术验证了血浆中坎地沙坦的含量。材料与方法:使用Betasil C8(100×2.1)进行反相色谱分离mm)5μm色谱柱,甲醇:三氟乙酸铵缓冲液的流动相,甲酸(60:40 v / v),流速为0.45 ml / min。通过使用质谱仪的多反应监测,以正电离对质子化的分析物进行定量。以普萘洛尔为内标,使用质量变迁m / z 441.2→263.2和260.2→116.1来测定坎地沙坦。结果:所开发方法的线性在1.2–1030 ng / ml范围内实现(r2≥0.9996)结论:所开发的方法简便,快速,准确,具有成本效益且具有针对性;适用于坎地沙坦。因此,它可以用于制药行业的常规分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号